NEGATIVE AIR PRESSURE DEVICES AND USES THEREOF

Abstract
Provided herein are negative air pressure devices and uses thereof. In particular, provided herein are negative air pressure devices that modulate CO2 delivery for use in the treatment of sleep apnea.
Description
FIELD OF THE DISCLOSURE

Provided herein are negative air pressure devices and uses thereof. In particular, provided herein are negative air pressure devices that modulate CO2 delivery for use in the treatment of sleep apnea and related conditions.


BACKGROUND

Sleep apnea is a serious public health problem. The prevalence of this disease is approximately 1.0 billion people worldwide. Continuous Positive Airway Pressure (CPAP) equipment is still considered the standard treatment for obstructive sleep apnea (OSA) and even some types of central and mixed sleep apnea, but positive airway pressure is not tolerated by many patients and therefore, CPAP is underutilized. In other words, CPAP is established as a highly efficacious treatment for OSA. However, its effectiveness has been limited by poor adherence. In fact, many patients with sleep apnea consider CPAP positive pressure to be extremely uncomfortable and drop out in less than 6 months. Between 46 and 83% of patients with obstructive sleep apnea were reported as non-adherent to treatment. Patients often experience nasal discomfort, air dryness, excess humidity, problems with mask fit, mask leak, high pressure discomfort, congestion, noise and claustrophobia.


What is needed are devices for treating sleep apnea that are simple, lightweight, and well tolerated by users.


SUMMARY

Provided herein are negative air pressure devices and uses thereof. In particular, provided herein are negative air pressure devices that modulate CO2 delivery for use in the treatment of sleep apnea and related conditions.


Provided herein is an improved treatment for sleeping apnea that is much more comfortable and effective than existing devices such as CPAP. In some embodiments, provided herein are intermittent negative air pressure or continuous negative air pressure devices that utilize the Bernoulli principle and Venturi effect to deliver CO2 enriched air to subjects in need of treatment for sleep apnea. In some embodiments, the devices described herein do not require cleaning, are comfortable, and do not require electricity to operate.


Accordingly, in some embodiments, provided herein is a negative air pressure device, comprising: a transport tube configured to transport air; at least one mixing chamber; at least one gas inlet in operable communication with the mixing chamber; and at least one inlet/outlet in operable communication with the mixing chamber. In some embodiments, the mixing chamber comprises one or more of primary, secondary, and tertiary mixing chambers, wherein the primary mixing chamber is proximal to the transport tube, the secondary mixing chamber is proximal to the primary mixing chamber and distal to the tertiary mixing chambers, chamber. In some embodiments, the device further comprises a face mask in operable communication with the transport tube (e.g., a face mask comprising valves). In some embodiments, the transport tube further comprises a nozzle in operable communication with the mixing chamber. In some embodiments, the transport tube further comprises an adjustment component configured to move the transport tube in closer or further proximity to the mixing chamber (e.g., an infinity screw or a motor).


In some embodiments, the inlet further comprises a valve configured to control the cross-sectional area of the inlet and/or flow of gas into the inlet. The present disclosure is not limited to particular valves. Examples include, but are not limited to, a two-way valve (e.g., a butterfly valve) or a one-way valve (e.g., an umbrella valve). In some embodiments, the device comprises two or more (e.g., 2 3, 4, 5, or more) inlets and/or outlets. In some embodiments, the valve is configured to move with the axis of the inlet (e.g., via a screw motor). In some embodiments, the outlet is covered by a filter. In some embodiments, a secondary flow inlet causes the flow to enter tangentially with respect to the mixing chamber. In some embodiments, the secondary flow enters radially with respect to the main flow. In some embodiments, the outlet/inlet comprises a valve. The present disclosure is not limited to a location of the inlet. In some embodiments, the inlet is located on the top of the mixing chamber, on the side of the transport tube, or another location. In some embodiments, the inlet comprises an actuator that controls movement of air through the actuator.


In some embodiments, the mixing chamber comprises a region that can be constricted. The present disclosure is not limited to a constriction method. Examples include, but are not limited to, a valve or a diaphragm. In some embodiments, the constriction generates negative pressure via the venturi effect.


In some embodiments, the device is enclosed in a case. In some embodiments, the device further comprises an external source of gas (e.g., CO2 or air) in operable communication with the device. In some embodiments, the device provides intermittent, periodic, or continuous negative air pressure (e.g., via the venturi effect). In some embodiments, the device traps CO2 in the mixing chamber.


Further embodiments provide a system, comprising: a) a device described herein; b) a sensor (e.g., one or more of a CO2 sensor, air flow sensor, temperature sensor, pressure sensor, or any sensor able to correlate with respiration); and c) a processor configured to use an algorithm to control the CO2 levels provided by the device. In some embodiments, the processor controls CO2 levels by controlling flow of atmospheric air or enriched CO2 air into the device through the inlet. In some embodiments, the system comprises a controller that controls operation of the device in order to modulate CO2 levels and/or airflow in the device.


Yet other embodiments provide a method of treating sleep apnea in a subject, comprising: applying the device or system described herein to a subject in need thereof. The devices, systems, and methods described herein are suitable for use in treating any type of sleep apnea (e.g., including but not limited to, obstructive, central or mixed sleep apnea).


Additional embodiments are described herein.





DESCRIPTION OF THE FIGURES


FIG. 1 shows an exemplary device of embodiments of the present disclosure.



FIG. 2 shows an exemplary device of embodiments of the present disclosure with a side inlet.



FIG. 3 shows an exemplary device of embodiments of the present disclosure with an inlet valve.



FIG. 4 shows an exemplary device of embodiments of the present disclosure with an inlet valve.



FIG. 5 shows an exemplary device of embodiments of the present disclosure with a Y shape venturi effect component.



FIG. 6 shows an exemplary device of embodiments of the present disclosure with a symmetrical venturi effect component



FIG. 7 shows an exemplary device of embodiments of the present disclosure with a symmetrical venturi effect component located at an inlet.



FIG. 8 shows an exemplary device of embodiments of the present disclosure with a symmetrical shape venturi effect component located in a valve in a secondary inlet.



FIG. 9 shows an exemplary device of embodiments of the present disclosure with a blower component.



FIG. 10 shows an exemplary device of embodiments of the present disclosure with a tangential secondary flow.



FIG. 11 shows an exemplary mask for use with devices of embodiments of the present disclosure.



FIG. 12 shows an algorithm logic flow for controlling CO2 levels.



FIG. 13 shows an exemplary CAD embodiment of the main body with a constraint in the middle to improve the mixing of the gases.



FIG. 14 shows a picture of the device constructed according to the CAD design shown in FIG. 13.



FIG. 15 shows experimental data obtained using the device of FIG. 14.





DETAILLED DESCRIPTION

Provided herein are negative air pressure devices and uses thereof. In particular, provided herein are negative air pressure devices that modulate CO2 delivery for use in the treatment of sleep apnea.


The devices described herein are based, in part, on the Bernoulli principle, Venturi effect, and mass and energy transfer equations. Common realizations of these concepts in other systems are (a) ejectors, (b) injectors, (c) air jets, (d) educators, (e) jet pumps, (f) carburetors, (g) cyclonic separators etc. The Bernoulli theorem teaches us that the energy of flowing fluid (for small height differences) remains constant, but this energy can take a form of either kinetic energy or potential energy (in the pure form of pressure for horizontal flow). In order words, if a fluid accelerates its pressure will drop and vice-versa, while the total energy remains unchanged. For air flowing in a tube, the changes in pressure and velocity can be made to occur by narrowing or widening the tube or sections of the tube. For example, one can decrease the pressure and thus increase the velocity of a fluid by creating a reduction in the cross-section area (a throat). The cross-section area of the tube or of the constraint can have any shape, e.g. circular or rectangular. The same effect of changing pressure and kinetic energy can be created using nozzles. Because of the increase in the velocity, the pressure of the moving fluid becomes lower than of any surrounding fluids, which cause the latter to flow toward the area of lower pressure similarly the way air flows into vacuum.


The Bernoulli principle and the Venturi effect show that regions where a fluid has a higher velocity causes a negative pressure. In other words, an increase in the speed of a fluid occurs simultaneously with a decrease in pressure or a decrease in the fluid's potential energy. In the present disclosure, these principals are used to create a region of low pressure that can be used to control the mixing between atmospheric air and either exhaled air and/or other gases such as CO2 or O2. Because the devices described herein allow for control of the lower pressure, one can control both the intensity and the direction of the secondary gas and thus the mixing of the gas. Thus, contamination of the non-disposable parts is avoided. Moreover, there is no need to use valves to control the amount of CO2 inside the mixing chamber, however one can still use them if desired. Also, in some embodiments, the tube throat is constrained by an exterior actuator without putting it in direct contact with the exhaled air. In some embodiments, a valve, diaphragm, needle of any other means is used to reduce the cross-section in the tube both/either at the exit/exits and/or in the inlets (primary or secondary). More or less cross-section area provides a more or less differential pressure and hence more or less mixing. Again, this avoids contamination since the air only travels from the outside (atmospheric) to the inside of the mixing chambers if there is a constraint in the tube.


The devices described herein do not need to be rigid and can be constructed of any type of appropriate fiber or other material, e.g., paper, cardboard, plastic, metal or alloy (e.g., stainless steel), and ceramic. Because the devices can be constructed of an absorbing material, the device can control excess moisture (a common complain of CPAP users) and be disposable so cleaning is not needed (another common complain of CPAP users) and inexpensive to manufacture. Because the pressures involved are small (typically less than 20 mmHg), the mask and/or nasal pillows do not need to be very tight to avoid leaks, which are a source of complaint among users of PAP machines.


In some embodiments of the device, the venturis are asymmetrical because in most of the applications a fluid can be adequately mixed in only one direction. However, in the devices described herein, they can be symmetrical, so the atmospheric air is mixed inside of the device in both the inhale and exhale phases in a similar fashion. Another advantage of the devices of the present disclosure is that they do not require a fan or blower to create the negative pressure but rather uses the kinetic energy of the inspired and/or expired air from the user to create the differential pressure. Thus, no third source of energy is necessary.


Further provided herein is a computer-controlled algorithm to control the amount of CO2 based on one or more parameters (e.g., concentration of CO2 in the device or mask, detection of apneic event, etc.). The apneic event can be detected by changes or lack of variation of flow, pressure, gas concentration, temperature, humidity, electrical resistivity, sound and/or electromagnetic changes inside or outside of the chamber and/or the mask. Alternatively, or in combination, it can be detected by pulse oximetry, chest movement strain gage attached to the device or patient, chest movement image, and/or video. However, it is preferable not to be in contact with the interior of the primary or secondary chambers to avoid contamination and hence the need of cleaning.


In some embodiments, the devices described herein treat sleep apnea by delivering amounts of CO2 either generated by patients during the exhale phase of the respiration or by an external gas reservoir or by concentrating the natural occurred CO2 in the atmosphere. In some embodiments, the amount of CO2 delivered to the patient is controlled based on the measurements of the individuals' respiratory instability, e.g., hypoapnea or apnea events.


Accordingly, provided herein are Variable Negative Air Pressure device (VNAP) or Constantly Negative Air Pressure (CNAP) devices for use in treating sleep apnea. While the present devices are exemplified with controlling the amount of CO2 delivered to the patients during the respiratory cycle in order to stabilize their respiration, the present disclosure is not limited to CO2 regulation. In some embodiments, the device is used to control the amount of any other gases exhaled by the patient such as, for example, O2, N2, etc. Exemplary devices are described herein.


In some embodiments, the VNAP or CNAP comprises at least one (e.g., all three) modules: (1) a chamber comprise a venturi, air injector, air ejector or educator based on the Bernoulli principle to vary the mixing between the fresh/atmosperic air and CO2 by using one or more actuators; (2) one or more sensors to detect apnea or hypoapnea; and (3) a control mechanism for delivering the required amount of CO2 used to stabilize the patients' respiration.



FIG. 1 shows a schematic drawing of one of the embodiments that used the air ejector principle. In this case, the amount of fresh air is controlled by the inserted tube position with respect to the primary mixing chamber.



FIG. 1 shows mask 1, transport tube 2, transport tube adjustment component 3, mixing chamber 4, outlet/inlet 5, gas inlet 8, optional nozzle 10, actuator 6, and case 7.


Still referring to FIG. 1, the present disclosure is not limited to particular designs for mask 1. The mask can be any of the commonly used PAP masks or nose pillow or any other mask suitable to be used in exchanging gases from and to the subject. However, since the involved pressures are not as high as occurred in the PAP machines, it is not necessary to be as tightly attached to the users' face or nostrils as in the case of the PAP devices and thus it is more comfortable and more flexible. In some embodiments, mask 1 comprises a plurality of valves as shown in FIG. 10. In some embodiments, the mask is obtained from commercial sources (e.g., from 3M corporation, St. Paul, Minn., Honeywell, Morris Plains, N.J. or other sources).


Still referring to FIG. 1, in some embodiments, the device comprises a transport tube adjustment component configured to move the nozzle in closer proximity to the mixing chamber. This allows for control of negative pressure and the corresponding flow rate. The present disclosure is not limited to particular adjustment components. Examples include, but are not limited to, an electric motor with or without gears or chains, an infinity screw (e.g., 370C-08700-N-CV, Transmotec, Boston, Mass.) or a piezoelectric motor (e.g., Piezo LEGSĀ® Linear 6N, PiezoMotor, Uppsala, Sweden), pneumatic actuator (e.g., MA-250 X 0.25-DA-RS, Universal Power Conversion, Savage, Minn.), or any other material that can contract, expand, shift or rotate due to stimulus such as voltage, electrical current, and temperature (e.g., artificial muscle).


Still referring to FIG. 1, the present disclosure is not limited to particular materials for transport tube 2. The tube can be made of any biocompatible material or medical grade material, rigid or flexible.


Still referring to FIG. 1, a gas inlet 8 is shown. The gas inlet provides the atmospheric air or any other gas or combination of gases from a third source such as, for example, CO2, O2, N2, etc. The inlet does not need to have a valve. However, in some embodiments, a valve is added (not shown in FIG. 1) to control its cross-section area and hence the flow rate. The present disclosure is not limited to particular valves. In some embodiments, the valve is a two-way valve, such as, for example, a butterfly valve or one-way valve such as, for example, an umbrella valve that allows only the flow to inside the device, or a combination of valves either passive or active such as solenoid or motorized valves that can control the flow rate in one or both directions. In some embodiments, the inlet is connected to a pump to provide additional gases (not shown in FIG. 1). FIG. 1 shows a single inlet 8. In some embodiments, two or more (e.g., 2, 3. 4, 5, or more) inlets 8 are utilized. In some embodiments, several inlets are connected (e.g., at low pressure regions) along the surface of the device or in parallel or in series or in combination. In some embodiments, the inlet or inlets 8 are tangential to the device, improving the mixing of gases. In some embodiments, the inlet or inlets 8 are tangential to the device, improving the mixing of gases as shown in FIG. 14.


The present disclosure is not limited to a particular location of inlet 8. In FIG. 8, the inlet is shown on the top of mixing chamber 4. However, the inlet 8 may be located in any suitable location of mixing chamber 4.


Still referring to FIG. 1, the present disclosure is not limited to particular designs of the mixing chamber 4. In some exemplary embodiments, as shown in FIG. 1, the mixing chamber comprises a plurality of chambers (e.g., primary, secondary, and tertiary chambers). In some embodiments, the primary mixing chamber is proximal to the transport tube, the secondary mixing chamber is proximal to the primary mixing chamber and distal to the tertiary mixing chamber. In some embodiments, the primary mixing chamber 9 is located next to and in operable communication with the transport tube. In some embodiments, the secondary mixing chamber 11 server as a diffuser or conduit to the tertiary mixing chamber 12 that further mixes the gases and stores the gases to be inhaled by the patient in the next respiratory cycle. In some embodiments, the secondary mixing chamber 11 increases the static pressure to reduce the velocity of the excess gases into the atmosphere. In some embodiments, the tertiary mixing chamber 12 stores gases. In some embodiments, the tertiary mixing chamber 12 has a volume of 200 to 2000 ml (e.g., 200, 500, 1000, 1500, or 2000 ml).


Still referring to FIG. 1, the outlet/inlet 5 is where gases return to the atmosphere or enter the device from the atmosphere. In some embodiments, the outlet/inlet 5 comprises a passive or active valve in order to increase the pressure inside the device. In some embodiments, when the valve is closed, all gas intake and outflow flow through port 8.


Still referring to FIG. 1, in some embodiments, devices comprises a case 7 to hold the structure in place and to protect the internal structure. In some embodiments, the case 7 is solid, malleable, closed or with apertures. The present disclosure is not limited to particular materials for the case 7. Examples include, but are not limited to, metal, alloys, polymers or wood.


Still referring to FIG. 1, in some embodiments, devices comprise a nozzle 10 located at the distal end of the transport tube 2. In some embodiments, nozzle 10 serves to accelerate the exhaled air to create a negative pressure in the chamber, allowing the atmospheric air or other gas or gases to enter the mixing chamber 4. The nozzle diameter can be fixed or variable to control the velocity of the exhaled air and hence the negative pressure and flow rate through transport tube 2. The nozzle 10 shown in FIG. 1 has a converging tip to accelerate the flow and hence increase the negative pressure. However, the present disclosure is not limited to a nozzle 10 with a converging tip. In some embodiments, a nozzle 10 with a constant cross-section is used (e.g., a nozzle with a diameter that is smaller than the mixing chamber 4 diameter). In some embodiments, a converging-diverging nozzle 10 is used. In some embodiments, the nozzle 10 has a lower diameter than the mixing chamber 4 or primary mixing chamber 9. If the nozzle 10 is completely flush with the mixing chamber 4, less mixing occurs with the atmospheric air. If the nozzle 10 is moved away from the entrance to the mixing chamber 4, there is no mixing with gases stored in the mixing chamber 4. Between the two extreme positions, more or less mixing occurs. Although only one nozzle is shown in FIG. 1, in some embodiments, 2 or more (e.g., 2, 3, 4, 5 or more) nozzles are used. Although the inlet 8 is shown in FIG. 1 is radial, a tangential inlet is also suitablet, which further improve the mixing of gases reducing the need of longer length to properly mix the gases as shown in FIG. 10.



FIGS. 2-11 and 13-14 show additional designs and embodiments of the disclosed devices.


Now referring to FIG. 2, shown is a device where air enters the device on the side of transport tube 2 through the sides of the transport tube 2 where it enters the mixing chamber 4 as shown by the arrows. In both FIGS. 1 and 2, the amount of atmospheric air that is mixed is controlled by the relative position of the transport tube 2 and mixing chamber 4. When the transport tube 2 is completely flush with the mixing chamber 4, mixing with atmospheric air occurs only at outlet/inlet 5. Thus, the amount of CO2 in the mixing is maximum.


Now referring to FIG. 3, shown is a device that comprises a butterfly valve (or other valve) 13 in the gas inlet 8. In some embodiments, the valve (e.g., butterfly valve) is used in combination with the transport tube adjustment component 3 and/or other components described herein.


Now referring to FIG. 4, shown is a device where the flow of air through gas inlet 8 is controlled by constricting the gas inlet 8 with a screw (shown in FIG. 4) or other component that is able to constrict the gas inlet 8.


Now referring to FIG. 5, a device is shown where nozzle 10 is generated by an actuator 14. When the actuator 14 rotates counter clockwise it can completely shuts the passage through gas inlet 8 so there is no mixing air will occur through outlet/inlet 5. Thus, maximum gas modulation treatment occurs. When the actuator 14 moves clockwise, it becomes a nozzle 10 with variable cross-sectional area depending on the angle or the rotation.


Now referring to FIG. 6, shown is a device where the flow of air is controlled by constricting a region of mixing chamber 4. In FIG. 6, a point of constriction 15 is shown in the center (e.g., symmetrical venturi) of mixing chamber 4. However, the constriction can be placed in any suitable location. When the chamber is constrained in location 15 (e.g., reduced cross-section area) the air velocity increases and hence a negative pressure occurs. The constraint can be done in any way to change the cross-section area including, but not limited to, a butterfly valve, a diaphragm, guillotine valve, pinch valve etc. The negative pressure and hence the secondary flow is controlled by varying cross-section area of the constriction.


Now referring to FIGS. 7 and 8, shown are embodiments where the air control is based on constraint of the gas inlet 8. In the embodiments, shown in FIG. 7, a physical constraint of the gas inlet 8 is used to control flow through the gas inlet 8. However, the present disclosure is not limited to a constraint. Other control component may be used (e.g., a screw as shown in FIG. 4 or a valve as shown in FIG. 8). In the embodiment shown in FIG. 7, the gas inlet 8 is placed in distal portion of a symmetrical venturi mixing chamber. However, the gas inlet 8 can be placed in any suitable location of the reduced cross-sectional area.


Now referring to FIG. 9, shown is a device comprising a blower component 16. The negative pressure and hence the mixing is controlled by an external blower, fan or pump. The negative pressure can be controlled not only by the options described in FIGS. 1-8, but also by the velocity of the blower. The blower can blow the atmospheric air from left to right or from right to left. However, it is more advantageous if is from left to right since the exhaled air does not get in contact with the blower, hence does not require a filter or constant cleaning of the blower. The present disclosure is not limited to a single blower. In some embodiments, 2 or more blowers are utilized in series or in parallel. The blower can be of any type including, but not limited to, positive displacement, helical screw, centrifugal, regenerative, syringe pump, diaphragm pump, piezoelectric or any other means for displacing air or gases. Commercially available blowers include, but are not limited to, those available from Master Flex (Cole-Panner, Vernon Hills, Ill.).


Now referring to FIG. 10, shown is an embodiment where a secondary flow inlet 30 is provided. In the embodiment shown in FIG. 10, the secondary flow inlet 30 enters tangentially to the mixing chamber 31. In some embodiments, this improves the mixing of expired air and atmospheric air.


Now referring to FIG. 13, shown is a CAD design of an exemplary device. The inlet 17 guides the respiration flow into the device. The valve 19 (including components 18 and 20) moves right/left to allow more or less mixing with the atmospheric that enters the device. The valve 19 moves according to the movement of the screw motor 26 protected by the cap 27. The protection caps 24 and 25 protect the main body 21, 22 and 23 and the outlet is covered by a filter 28. All parts can be built in one piece but are divided in FIG. 13 to show an exemplary injection molding or 3D print plan.


Now referring to FIG. 14, shows in a physical realization of the CAD design of FIG. 13 plus the mask and hose.


Now referring to FIG. 15, shown are experimental results obtained using the device shown in FIG. 14. Number 1 shows the concentration of CO2 inside the mixing chamber when the valve is completely closed. Thus, the secondary flow is minimum. Number 2 shows the concentration of CO2 when the valve is completely open. Hence, the secondary flow is maximum. Number 3 shows the variation of the concentration of CO2 according the aperture of the valve, from maximum aperture to minimum aperture. In the experiment, a metabolic simulator with mass flow controller (Vacumed, Calif.) was used. A CO2 (100% concentration) tank was connected to the simulator at a mass flow that creates a maximum concentration of 7000 ppm of CO2 when the valve at the secondary flow is completely shut. The simulator was set to a tidal volume of 0.5 Liter/min and respiration rate of 15 respirations/minute, which are typical of a normal adult at rest state.


The present disclosure is not limited to particular sizes of devices. In some embodiments, the effective cross-section area of the device is larger than the cross-section area of a cylinder of 10 mm in diameter in order to avoid extra resistance to normal respiration. However, any specific cross-section area can be used given another path for the flow of gases to occur. For example, the mixing chamber can have a diameter of 0 mm if the transport tube and inlet have effective diameters in combination of at least 15 mm. In this case, all the flow occurs from the inlet and transport tube with minimal addition of excess CO2 or other gas/gases.


Further provided herein are systems comprising the devices described herein, a CO2 sensor, and a processor and algorithm that controls CO2 delivery by the device based on feedback from the CO2 sensor and/or the patient. In some embodiments, systems include a controller (e.g., controlled by the processor) that controls function of the device in order to modulate CO2 levels and/or airflow through the device.


The present disclosure is not limited to particular CO2 sensors. In some embodiments, commercially available CO2 sensors are utilized (e.g., available from Kele, Memphis, Tenn. or any number of other commercial suppliers). In some embodiments, the CO2 sensor is located in a suitable location or locations of the device in order measure the level of CO2 in the mixing chamber (e.g., including but not limited to, internal to the mixing chamber or external with access via an inlet or valve).


In some embodiments, systems include components to detect apnea in a patient. The apneic event may be an apnea or a hypopnea, or the apneic event may be the absence of normal respiration (e.g., the temporary cessation of breathing) or a hypopnea (e.g., abnormally slow or shallow breathing). For example, one or more sensors are provided in the airstream that measure the flow rate of each breath of the wearer and may sense the slowing or cessation of breathing or a reduction in airflow. The sensor may also be a pulse oximeter, a thermal sensor, an optical sensor, or the like, or combinations of the foregoing, as well as combinations of any of the sensors described herein. Accordingly, apneas may be detected, for example by pulse oximetry, or a thermal flow sensor (such as hot wire anemometer), or an optical sensor (such as that detects movement of a drag sensor), or a flow sensor (such as a pneumotachometer).


In some embodiments, when apnea is detected, the controller controls the levels of CO2 or the negative pressure in the device (e.g., by adjusting one or more valves, blowers, etc.) in order to treat the apnea. In some embodiments, the sensor is configured to take readings at regular intervals (e.g., every microsecond, millisecond, second, minute, or longer intervals). The algorithm and processor then determine if apnea or hypoapnea is present and directs the controller to adjust the device accordingly.


In some embodiments, the controller further controls valves present in a mask as shown in FIG. 11. For example, in some embodiments, when the sensor detects normal respiration, the controller closes all the inlets/outlets of the valve, which decreases the differential pressure inside the mask during inspiration and increases the differential pressure during the respiration phase. In such embodiments, two one-way valves (as shown in FIG. 11) or a two-way valve both with preset open and close pressure will open, allowing the patient to breathe through the mask as shown in FIG. 11.


As described herein, the present disclosure provides methods of treating apnea using the devices and systems described herein. The devices and systems are suitable for treatment of any type of apnea (e.g., obstructive, central or mixed sleep apnea).


All publications, patents, patent applications and accession numbers mentioned in the above specification are herein incorporated by reference in their entirety. Although the disclosure has been described in connection with specific embodiments, it should be understood that the disclosure as claimed should not be unduly limited to such specific embodiments. Indeed, various modifications and variations of the described compositions and methods of the disclosure will be apparent to those of ordinary skill in the art and are intended to be within the scope of the following claims.

Claims
  • 1. A negative air pressure breathing device comprising an air chamber configured to move air via a venturi effect.
  • 2. The device of claim 1, comprising: a transport tube configured to transport air; at least one mixing chamber; at least one gas inlet in operable communication with said mixing chamber; and at least one inlet/outlet in operable communication with said mixing chamber.
  • 3. The device of claim 2, wherein said mixing chamber comprises primary, secondary, and tertiary mixing chambers, wherein said primary mixing chamber is proximal to said transport tube, said secondary mixing chamber is proximal to said primary mixing chamber and distal to said tertiary mixing chamber.
  • 4. The device of claim 1, wherein said device further comprises a face mask in operably communication with said transport tube.
  • 5. The method of claim 1, wherein said transport tube further comprises a nozzle in operable communication with said mixing chamber.
  • 6. The device of claim 1, wherein said transport tube further comprises an adjustment component configured to move said transport tube in closer or further proximity to said mixing chamber.
  • 7. (canceled)
  • 8. The device of claim 1, wherein said inlet further comprises a valve configured to control the cross-sectional area of said inlet.
  • 9-11. (canceled)
  • 12. The device of claim 1, wherein said device comprises two or more inlets and/or outlets.
  • 13. The device of claim 1, wherein said outlet/inlet comprises a valve.
  • 14-15. (canceled)
  • 16. The device of claim 1, wherein said inlet comprises an actuator that controls movement of air through said actuator.
  • 17. The device of claim 1, wherein said device further comprises a secondary flow inlet.
  • 18. The device of claim 17, wherein said secondary flow inlet enters said device tangentially to said mixing chamber.
  • 19. The device of claim 8, wherein said valve is configured to move with the axis of the inlet.
  • 20-21. (canceled)
  • 22. The device of claim 1, wherein said mixing chamber comprises a constrictable region.
  • 23. The device of claim 22, wherein constriction generates negative pressure via the venturi effect.
  • 24-26. (canceled)
  • 27. The device of claim 1, wherein said device further comprises an external source of gas in operable communication with said device.
  • 28. The device of claim 1, wherein said device provides intermittent, periodic, or continuous negative air pressure.
  • 29. The device of claim 1, wherein said device traps CO2 in said mixing chamber.
  • 30. A system, comprising: a) the device of claim 1;b) at least one sensor selected from the group consisting of a CO2 sensor, a pressure sensor, a temperature sensor, and an air flow sensor; andc) a processor configured to use an algorithm to control CO2 levels or airflow provided by said device.
  • 31-32. (canceled)
  • 33. A method of treating sleep apnea in a subject, comprising: applying the device of claim 1 to a subject in need thereof.
  • 34-36. (canceled)
Parent Case Info

This application claims the benefit of U.S. provisional application Ser. No. 62/727,331, filed Sep. 5, 2018, which is incorporated herein by reference in its entirety.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2019/049704 9/5/2019 WO 00
Provisional Applications (1)
Number Date Country
62727331 Sep 2018 US